Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) FCF Margin (2022 - 2025)

Historic FCF Margin for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to 20760.87%.

  • HCW Biologics' FCF Margin fell 200415000.0% to 20760.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 3073.46%, marking a year-over-year decrease of 24752400.0%. This contributed to the annual value of 632.61% for FY2024, which is 3779000.0% up from last year.
  • Per HCW Biologics' latest filing, its FCF Margin stood at 20760.87% for Q3 2025, which was down 200415000.0% from 50111.5% recorded in Q2 2025.
  • In the past 5 years, HCW Biologics' FCF Margin ranged from a high of 51.83% in Q1 2022 and a low of 69375.24% during Q1 2025
  • Over the past 4 years, HCW Biologics' median FCF Margin value was 719.37% (recorded in 2024), while the average stood at 10468.83%.
  • As far as peak fluctuations go, HCW Biologics' FCF Margin soared by 88893800bps in 2024, and later crashed by -688608100bps in 2025.
  • Over the past 4 years, HCW Biologics' FCF Margin (Quarter) stood at 287.59% in 2022, then tumbled by -100bps to 574.81% in 2023, then fell by -29bps to 743.32% in 2024, then crashed by -2693bps to 20760.87% in 2025.
  • Its FCF Margin stands at 20760.87% for Q3 2025, versus 50111.5% for Q2 2025 and 69375.24% for Q1 2025.